← FDA DRUG APPROVALS

FDA ANDA · ANDA062268

CLOXACILLIN SODIUM

Sponsor: TEVA

APPLICATION
ANDA062268
TYPE
ANDA
ORIGINAL APPROVAL
1980-09-15
LATEST ACTION
2000-07-07
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

CLOXACILLIN SODIUMDiscontinued
CLOXACILLIN SODIUM EQ 125MG BASE/5ML · FOR SOLUTION · ORAL

Approval history

2000-07-07Manufacturing (CMC) · Supplement 20AP
1997-12-22Manufacturing (CMC) · Supplement 19AP
1997-08-19Manufacturing (CMC) · Supplement 18AP
1996-08-30Manufacturing (CMC) · Supplement 17AP
1994-12-22Manufacturing (CMC) · Supplement 16AP
1994-01-13Labeling · Supplement 14AP
1993-06-29Labeling · Supplement 15AP
1980-09-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →